
DOJ and DEA Order Immediately Reschedules FDA-Approved and State-Licensed Medical Cannabis to Schedule III: What Operators Need to Know
On April 23, 2026, the United States Department of Justice and the Drug Enforcement Administration announced an order that marks the most consequential shift in federal cannabis policy in more than five decades. Acting Attorney General Todd Blanche signed an order that immediately places both FDA-approved cannabis products and state-regulated medical cannabis products into Schedule […]
Author: Daniel T. McKillop














